Holding/activity history for BioMarin Pharmaceutical Inc. (BMRN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 8,914,025 | 0.56 | $70.29 | ||
| 2024 Q2 | 8,914,025 | 0.69 | $82.33 | ||
| 2024 Q1 | 8,914,025 | 0.72 | $87.34 | ||
| 2023 Q4 | 8,914,025 | 0.88 | $96.42 | ||
| 2023 Q3 | 8,914,025 | 0.87 | Add 0.53% | 0.00 | $88.48 |
| 2023 Q2 | 8,867,025 | 0.85 | Add 0.36% | 0.00 | $86.68 |
| 2023 Q1 | 8,834,825 | 0.98 | $97.24 | ||
| 2022 Q4 | 8,834,825 | 1.05 | Reduce 1.89% | 0.02 | $103.49 |
| 2022 Q3 | 9,005,225 | 1.07 | Add 0.21% | 0.00 | $84.77 |
| 2022 Q2 | 8,986,725 | 0.89 | $82.87 | ||
| 2022 Q1 | 8,986,725 | 0.72 | $77.10 | ||
| 2021 Q4 | 8,986,725 | 0.83 | $88.35 | ||
| 2021 Q3 | 8,986,725 | 0.77 | Add 6.08% | 0.04 | $77.29 |
| 2021 Q2 | 8,471,425 | 0.81 | Add 25.51% | 0.16 | $83.44 |
| 2021 Q1 | 6,749,860 | 0.65 | Add 22.19% | 0.12 | $75.51 |
| 2020 Q4 | 5,524,125 | 0.69 | Add 33.33% | 0.17 | $87.69 |
| 2020 Q3 | 4,143,160 | 0.52 | Add 78.10% | 0.23 | $76.08 |
| 2020 Q2 | 2,326,325 | 0.48 | Reduce 7.73% | 0.04 | $123.34 |
| 2020 Q1 | 2,521,325 | 0.42 | Reduce 14.71% | 0.07 | $84.50 |
| 2019 Q4 | 2,956,325 | 0.34 | Buy | 0.34 | $84.55 |